Bausch & Lomb Corp
(STU:S2L)
€
14.6
+0.10 (+0.69%)
Market Cap: 5.24 Bil
Enterprise Value: 9.42 Bil
PE Ratio: 0
PB Ratio: 0.94
GF Score: 79/100 Bausch + Lomb Corp at Citi Global Healthcare Conference Transcript
Dec 03, 2025 / 02:00PM GMT
Release Date Price:
€14.4
(-1.37%)
Joanne Wuensch
Citigroup Global Markets Inc. - Analyst
Hello, and good morning, everybody, to day 2 of the Citibank Global Healthcare Conference here in Miami. And I am Joanne Wuensch, the medical technology analyst here. And I'm thrilled that we're going to start this session with the management of Bausch + Lomb, Brent Saunders, Chairman and CEO; and Sam, I'm going to clear your last name, sorry.
Sam Eldessouky;Lomb Corp;Chief Financial Officer
Bausch;Executive Vice President
+- -
Eldessouky.
Joanne Wuensch
Citigroup Global Markets Inc. - Analyst
I feel like with Wuensch, I get away with doing that.
Questions & Answers
Joanne Wuensch
Citigroup Global Markets Inc. - Analyst
Anyway, I remember when Bausch + Lomb was spun out several years ago in its IPO, and a lot has changed. And we were just talking before we started this presentation about your Analyst Day, which sort of like gave us the catch-up speech. But I'd
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot